Corient Private Wealth
MET icon

Corient Private Wealth’s MetLife MET Stock Holding History

Corient Private Wealth’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.6M Sell
503,635
-1,347,662
-73% -$101M 0.05% 292
2025
Q4 		$144M Buy
1,851,297
+1,265,568
+216% +$100M 0.1% 198
2025
Q3 		$48.2M Sell
585,729
-428,543
-42% -$33.7M 0.08% 238
2025
Q2 		$81.6M Buy
1,014,272
+462,367
+84% +$35.7M 0.11% 177
2025
Q1 		$44.3M Sell
551,905
-6,148
-1% -$511K 0.07% 238
2024
Q4 		$46.6M Sell
558,053
-70,949
-11% -$5.9M 0.08% 234
2024
Q3 		$51.9M Buy
629,002
+34,883
+6% +$2.61M 0.08% 236
2024
Q2 		$41.7M Sell
594,119
-12,722
-2% -$908K 0.07% 253
2024
Q1 		$45M Sell
606,841
-17,232
-3% -$1.2M 0.08% 237
2023
Q4 		$41.3M Buy
624,073
+4,127
+0.7% +$258K 0.08% 252
2023
Q3 		$39M Sell
619,946
-17,705
-3% -$1.1M 0.09% 238
2023
Q2 		$36M Buy
637,651
+252,568
+66% +$14M 0.08% 242
2023
Q1 		$22.3M Buy
385,083
+26,837
+7% +$1.81M 0.06% 282
2022
Q4 		$25.9M Buy
+358,246
New +$25.7M 0.09% 230

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corient Private Wealth's MET Position: Q1 2026 in Review

Corient Private Wealth reduced its MetLife (MET) stake by 73% in Q1 2026, selling an estimated $101M and leaving 503,635 shares worth $35.6M. The position accounts for 0.05% of the portfolio, ranked #292.

Corient Private Wealth first reported a position in MET in Q4 2022 and has held it in 14 quarters since. The position peaked at $144M in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Corient Private Wealth held 503,635 shares of MetLife worth $35.6M as of Q1 2026.
  • Corient Private Wealth sold 1,347,662 MetLife shares in Q1 2026, an estimated $101M.
  • MetLife made up 0.05% of Corient Private Wealth's portfolio in Q1 2026, its #292 holding.
  • Corient Private Wealth first reported a position in MetLife in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's MetLife position peaked at $144M in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.